Expediente |
2024/S 000-019556 |
Organismo |
NHS England |
Código Postal |
|
Fecha de publicación |
26/06/2024 |
Section one: Contracting authoritySection I: Contracting authorityone.1) Name and addressesI.1) Name and addressesNHS England
7-8 Wellington Place
Leeds
LS1 4AP
ContactKatie Noonan
Emailkatie.noonan@nhs.net
CountryUnited Kingdom
NUTS codeUK - United Kingdom
Internet address(es)Main addresshttps://www.england.nhs.uk/
Buyer's addresshttps://www.england.nhs.uk/
one.2) Information about joint procurementI.2) Information about joint procurementThe contract is awarded by a central purchasing body
one.3) CommunicationI.3) CommunicationThe procurement documents are available for unrestricted and full direct access, free of charge, at
https://health-family.force.com/s/Welcome
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://health-family.force.com/s/Welcome
Tenders or requests to participate must be submitted to the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authorityI.4) Type of the contracting authorityMinistry or any other national or federal authority
one.5) Main activityI.5) Main activityHealth
Section two: ObjectSection II: Objecttwo.1) Scope of the procurementII.1) Scope of the procurementtwo.1.1) TitleII.1.1) TitleNHS National Framework for Transition products commencing 1 October 2024
Reference numberCM/TNS/24/5712
two.1.2) Main CPV codeII.1.2) Main CPV code33600000 - Pharmaceutical products
two.1.3) Type of contractII.1.3) Type of contractSupplies
two.1.4) Short descriptionII.1.4) Short descriptionProject title: NHS National Framework for Transition products commencing 1 October 2024Offer reference number: CM/TNS/24/5712Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.Potential periods of call-offs under the framework agreement: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tabletsLot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) CM/TNS/24/5712/02 - ImatinibLot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Published By: Medicines Procurement and Supply Chain ? NHS Medicines Value & Access, NHS England
two.1.5) Estimated total valueII.1.5) Estimated total valueValue excluding VAT: £131,960,000
two.1.6) Information about lotsII.1.6) Information about lotsThis contract is divided into lots: Yes
Tenders may be submitted for all lots
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleCM/TNS/24/5712/01
Lot No1
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UK - United Kingdom
Main site or place of performancePlease refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
two.2.4) Description of the procurementII.2.4) Description of the procurementPeriod of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.Potential periods of call-offs under the framework agreement:CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tabletsLot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)
two.2.5) Award criteriaII.2.5) Award criteriaPrice
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £131,150,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemStart date1 October 2024
End date31 May 2026
This contract is subject to renewalNo
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: Yes
Description of optionsOption or options to extend (at the Authority?s discretion) for a period or periods up to a total of 24 months
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
two.2) DescriptionII.2) Descriptiontwo.2.1) TitleII.2.1) TitleCM/TNS/24/5712/02
Lot No2
two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)33600000 - Pharmaceutical products
two.2.3) Place of performanceII.2.3) Place of performanceNUTS codes
UK - United Kingdom
Main site or place of performancePlease refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
two.2.4) Description of the procurementII.2.4) Description of the procurementPeriod of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.Potential periods of call-offs under the framework agreement:CM/TNS/24/5712/02 - ImatinibLot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)
two.2.5) Award criteriaII.2.5) Award criteriaPrice
two.2.6) Estimated valueII.2.6) Estimated valueValue excluding VAT: £810,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing systemStart date1 October 2024
End date30 September 2025
This contract is subject to renewalNo
two.2.10) Information about variantsII.2.10) Information about variantsVariants will be accepted: No
two.2.11) Information about optionsII.2.11) Information about optionsOptions: Yes
Description of optionsOption or options to extend (at the Authority?s discretion) for a period or periods up to a total of 24 months
two.2.13) Information about European Union FundsII.2.13) Information about European Union FundsThe procurement is related to a project and/or programme financed by European Union funds: No
Section three. Legal, economic, financial and technical informationSection III. Legal, economic, financial and technical informationthree.1) Conditions for participationIII.1) Conditions for participationthree.1.2) Economic and financial standingIII.1.2) Economic and financial standingSelection criteria as stated in the procurement documents
three.1.3) Technical and professional abilityIII.1.3) Technical and professional abilitySelection criteria as stated in the procurement documents
Section four. ProcedureSection IV. Procedurefour.1) DescriptionIV.1) Descriptionfour.1.1) Type of procedureIV.1.1) Type of procedureOpen procedure
four.1.3) Information about a framework agreement or a dynamic purchasing systemIV.1.3) Information about a framework agreement or a dynamic purchasing systemThe procurement involves the establishment of a framework agreement
Framework agreement with several operators
four.1.8) Information about the Government Procurement Agreement (GPA)IV.1.8) Information about the Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative informationIV.2) Administrative informationfour.2.2) Time limit for receipt of tenders or requests to participateIV.2.2) Time limit for receipt of tenders or requests to participateDate29 July 2024
Local time1:00pm
four.2.4) Languages in which tenders or requests to participate may be submittedIV.2.4) Languages in which tenders or requests to participate may be submittedEnglish
four.2.6) Minimum time frame during which the tenderer must maintain the tenderIV.2.6) Minimum time frame during which the tenderer must maintain the tenderTender must be valid until: 27 October 2024
four.2.7) Conditions for opening of tendersIV.2.7) Conditions for opening of tendersDate29 July 2024
Local time1:00pm
PlaceNHS EnglandCommercial Medicines Unit,2nd Floor Rutland House,Runcorn,CheshireWA7 2ES
Information about authorised persons and opening procedureMPSC Employee
Section six. Complementary informationSection VI. Complementary informationsix.1) Information about recurrenceVI.1) Information about recurrenceThis is a recurrent procurement: No
six.2) Information about electronic workflowsVI.2) Information about electronic workflowsElectronic ordering will be used
Electronic payment will be used
six.3) Additional informationVI.3) Additional informationRESPONDING TO THIS NOTICE;Any supplier may be disqualified who does not respond to the following in the requisite manner:1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.ukCandidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:- agree to the user agreement- populate company details1.2) Once registered, candidates must register interest as follows:- log to the portal- select "Find Opportunities" from the supplier home screen, use the "Sort by:" facility to find this opportunity and select the bold blue title to select- review opportunity details and click "Register Interest"- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses.2) General supplier information.To manage and assess supplier information the Contracting Authority requests candidates provide theircompany profile in the Government's Supplier Registration Service (which has replacedsid4gov), as follows:2.1) If not already registered (the previous sid4gov password, login and details will stillbe on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.ukand select "Register" at the top of the page.Key in details as requested to search for your company. If you do not have a D-U-N-S®Number, click on the link at the right of the page to obtain a number from D&B.Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.D&B data will be supplied automatically by D&B.2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via themessage function on the website.OTHER CONTRACTING AUTHORITIESThe framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.
six.4) Procedures for reviewVI.4) Procedures for reviewsix.4.1) Review bodyVI.4.1) Review bodyThe High Court
The Strand
London
WC2A 2LL
CountryUnited Kingdom
Internet addresshttps://www.judiciary.uk/courts-and-tribunals/high-court/
Back to top
*Fecha Pub.: 26/06/2024
*Fuente ext: UK
*Enlace ext: https://www.find-tender.service.gov.uk/Notice/019556-2024